LexDanaLexDanabeta
Inventor

AN SONG

Inventor
US

Overview

3→
Patents
2025–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides27%
G01NInvestigating or analysing materials by determining their chemical or physical properties27%
A61KPreparations for medical, dental or toiletry purposes18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C12NMicroorganisms or enzymes9%
PatentTitleYear
12,596,122LILRB2 antibodies and uses thereof202612,559,555Anti-LILRB4 antibodies and derivative products202612,379,371In vitro transcytosis assay2025

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2025Patents assigned to GENENTECH INC (1)· patent assignee history
2025–2026Based in US· patent location history
2026Patents assigned to IMMUNE ONC THERAPEUTICS INC (2)· patent assignee history
2026Patents assigned to THE BOARD OF REGENTS OF THE UNIV OF TEXAS SYSTEM (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
IMMUNE ONC THERAPEUTICS INC22026
GENENTECH INC12025
THE BOARD OF REGENTS OF THE UNIV OF TEXAS SYSTEM12026
Locations
LocationPatentsSpan
US32025–2026